T. Bauer (Bochum, Germany), E. Ibrahim (Alexandria, Egypt)
Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP)
J. R. Badia, J. Ramirez, Y. Arce, M. Ferrer, S. Sanz, A. Cardesa, A. Torres (Barcelona, Spain)
|  |
Incidence and mortality of pneumonia in intensive care unit patients
P. J. Kuca, J. Wisniewska, A. Piwek, J. Burakowski, W. Z. Tomkowski (Warsaw, Poland)
|  |
Routine tracheal aspirates and adequacy of initial antibiotherapy of ventilator-associated pneumonia
L. Papazian, F. Michel, S. Donati, J. M. Sainty, M. Gainnier (Marseille, France)
| |
Klebsiella pneumoniae outgrowth in ARDS lungs is influenced by the ventilation strategy used
J. J. Haitsma, R. A. Lachmann, M. J. Schultz, M. van Haperen, B. Lachmann (Rotterdam, Amsterdam, The Netherlands)
| |
Epidemiology, clinical features and risk factors for adverse outcome of patients with pulmonary tuberculosis (TB) in an intensive care unit (ICU)
R. Erbes, A. de Roux, K. Oettel, M. Raffenberg, H. Mauch, H. Lode (Berlin, Germany)
| |
Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia
M. Cavalcanti, M. Ioanas, M. Ferrer, R. Ferrer, C. Agusti, J. Puig, A. Torres (Barcelona, Spain; Bucharest, Romania)
| |
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, M. H. Kollef (Alexandria, Egypt; Saint Louis, United States Of America)
| |
Characteristics and outcomes in patients with COPD receiving machanical ventilation: Indication, survival and occurance of ventilator-associated pneumonia
N. Nienhagen, U. Achtzehn, E. W. Schmidt (Chemnitz, Germany)
| |